Literature DB >> 27210509

Dietary ω-3 polyunsaturated fatty acid intake modulates impact of Insertion/Deletion polymorphism of ApoB gene on obesity risk in type 2 diabetic patients.

Masoumeh Rafiee1, Gity Sotoudeh2, Mahmoud Djalali1, Ehsan Alvandi1, Mohammadreza Eshraghian3, Fereshteh Sojoudi4, Fariba Koohdani5.   

Abstract

OBJECTIVES: The goal of the study described here was to determine whether dietary ω-3 polyunsaturated fatty acid (PUFA) intake modulates the association between ApoB Ins/Del polymorphism and obesity in type 2 diabetic patients.
METHODS: In this cross-sectional study, 700 patients with type 2 diabetes were recruited in Tehran. Weight and waist circumference (WC) were measured, and body mass index (BMI) was calculated. Dietary intake was assessed using a validated semiquantitative food frequency questionnaire. ApoB genotyping was performed with 8% polyacrylamide gel electrophoresis.
RESULTS: We observed a significant interaction between Ins/Del genotype and dietary ω-3 PUFA intake with respect to BMI, WC, and obesity risk in both unadjusted (P = 0.007, P = 0.001, and P = 0.021, respectively) and adjusted (P = 0.007, P = 0.04, and P = 0.002, respectively) samples. Thus, the carriers of the Del allele were only associated with lower BMI (P = 0.01) and WC (P = 0.002) among individuals with high ω-3 PUFA intake (≥0.6% of energy), but not in those with low ω-3 PUFA intake (<0.6%). Also, when dietary ω-3 PUFA was <0.6%, general obesity risk in carriers of the Del allele was about 1.6 times higher than that of Ins/Ins homozygotes (odds ratio = 1.59, 95% confidence interval: 1.05-2.52, P = 0.039). But with high ω-3 PUFA intake (≥0.6%), the risk was 0.46 times lower (odds ratio = 0.46, 95% confidence interval: 0.25-0.79, P = 0.003). Moreover, a similar interaction was observed in central obesity only in men after adjustment for confounder variables (P = 0.041).
CONCLUSIONS: These findings support the hypothesis that a diet high in ω-3 PUFA (≥0.6%) can decrease the obesity risk in carriers of the Del allele of ApoB gene.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  ApoB Ins/Del; Diabetes; Obesity; ω-3 Polyunsaturated fatty acids

Mesh:

Substances:

Year:  2016        PMID: 27210509     DOI: 10.1016/j.nut.2016.03.012

Source DB:  PubMed          Journal:  Nutrition        ISSN: 0899-9007            Impact factor:   4.008


  5 in total

1.  Habitual consumption of long-chain n-3 PUFAs and fish attenuates genetically associated long-term weight gain.

Authors:  Tao Huang; Tiange Wang; Yoriko Heianza; Yan Zheng; Dianjianyi Sun; Jae H Kang; Louis R Pasquale; Eric B Rimm; JoAnn E Manson; Frank B Hu; Lu Qi
Journal:  Am J Clin Nutr       Date:  2019-03-01       Impact factor: 7.045

2.  The interaction between apolipoprotein B insertion/deletion polymorphism and macronutrient intake on lipid profile and serum leptin and ghrelin levels in type 2 diabetes mellitus patients.

Authors:  Masoumeh Rafiee; Gity Sotoudeh; Mahmoud Djalali; Ehsan Alvandi; Mohammadreza Eshraghian; Fatemeh Javadi; Farideh Doostan; Fariba Koohdani
Journal:  Eur J Nutr       Date:  2018-01-27       Impact factor: 5.614

Review 3.  Dietary Fatty Acid Composition Modulates Obesity and Interacts with Obesity-Related Genes.

Authors:  Shatha S Hammad; Peter J Jones
Journal:  Lipids       Date:  2017-09-09       Impact factor: 1.880

4.  Attenuation of Metabolic Syndrome by EPA/DHA Ethyl Esters in Testosterone-Deficient Obese Rats.

Authors:  Nikhil S Bhandarkar; Senthil Arun Kumar; Jarad Martin; Lindsay Brown; Sunil K Panchal
Journal:  Mar Drugs       Date:  2018-05-24       Impact factor: 5.118

5.  Dietary quality indices modify the effects of apolipoprotein B polymorphisms on biochemical and anthropometric factors in type 2 diabetes mellitus.

Authors:  Elmira Karimi; Gity Sotoudeh; Masoumeh Rafiee; Fariba Koohdani
Journal:  Sci Rep       Date:  2021-11-17       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.